Beckman, Scopio to partner on blood smear platforms

2020 03 25 23 27 0591 Hands Shaking Deal 400

Beckman Coulter Diagnostics on Wednesday announced that it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood smear platforms.

Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.

Beckman Coulter and Scopio will expand on the strategic objectives of the partnership in a video interview at the LabPulse booth (#1740) at 2022 AACC.

Spinal fluid tests may aid PET scans of Alzheimer's disease
2022 03 02 20 27 6315 2022 03 04 Tau Biomarkers 400
Page 1 of 7
Next Page